Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer

Clinical trial NCT01824342 · COMPLETED

Trial details

NCT number: NCT01824342
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Castrate-resistant Prostate Cancer

Start date: 2011-01-01
Primary completion: 2014-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.